ARTICLE | Company News
HemaSure other research news
March 20, 1995 8:00 AM UTC
The Marlborough, Mass., company received a $723,000 Phase II SBIR from the Department of Defense, U.S. Army Medical Research Acquisition Activity, to develop a sterile system to remove cryoprotectants from previously frozen RBC concentrates. ...